Skip to main content

Peer Review reports

From: MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

Original Submission
19 Sep 2010 Submitted Original manuscript
15 Oct 2010 Reviewed Reviewer Report - Frederic Blanchard
26 Jan 2011 Reviewed Reviewer Report - frederique BRAUN
18 Mar 2011 Author responded Author comments - Hege Ohnstad
Resubmission - Version 2
18 Mar 2011 Submitted Manuscript version 2
24 Mar 2011 Reviewed Reviewer Report - Frederic Blanchard
31 Mar 2011 Reviewed Reviewer Report - frederique BRAUN
19 Apr 2011 Author responded Author comments - Hege Ohnstad
Resubmission - Version 3
19 Apr 2011 Submitted Manuscript version 3
11 May 2011 Author responded Author comments - Hege Ohnstad
Resubmission - Version 4
11 May 2011 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
20 May 2011 Author responded Author comments - Hege Ohnstad
Resubmission - Version 6
20 May 2011 Submitted Manuscript version 6
Publishing
30 May 2011 Editorially accepted
30 May 2011 Article published 10.1186/1471-2407-11-211

You can find further information about peer review here.

Back to article page